# 一位患有斑塊狀乾癬的病人預計開始服用 deucravacitinib。在第一劑之前，哪項發現需要澄清？

> source: MyMerci (mymerci.kr)  
> url: https://mymerci.kr/pages/nclex_q.php?qn_id=522934&lang=zh-tw  
> language: zh-TW  
> subject: Adverse Effects/Contraindications/Interactions  
> category: PPT

## 題目

一位患有斑塊狀乾癬的病人預計開始服用 deucravacitinib。在第一劑之前，哪項發現需要澄清？

## 選項

1. 病人上個月完成了非活性流感疫苗接種。
2. 病人計畫早餐時服用藥片。
3. 病人患有未經治療的潛伏性結核病，並預計下週接種活性疫苗。 **✔ 正確答案**
4. 病人使用無香料保濕劑來滋潤乾燥皮膚。

**正確答案: 3**

## 解析

在服用 deucravacitinib 之前，病人需要評估結核病並完成適當的免疫接種。活動性結核病是停藥條件，潛伏感染需要治療計畫，且治療期間應避免活性疫苗。

## 深入解析

快速解答
在服用 deucravacitinib 之前，澄清 未經治療的結核病風險和計畫中的活性疫苗。

為何這是正確的
TYK2 抑制可能增加感染風險。篩檢和預防計畫在免疫調節前進行；用餐時間和例行皮膚護理不會造成相同的即時安全衝突。

簡單類比或心像
建立藥物安全鏈：識別新的線索，將其與藥物機制或標示限制連結，停止可預防的暴露，穩定病人，並驗證可測量的反應。

記憶點
藥物、緊急線索、保護性措施和再評估終點。

NCLEX 決策規則
選擇能預防最直接藥物相關危害的措施，同時保留指示治療和所需監測。

為何其他選項是錯誤的
繼續可疑暴露、將標示的危險線索正常化、替代未經授權的劑量或延遲升級的選項會使病人處於危險之中。References
1DailyMed: SOTYKTU (deucravacitinib)感染和結核病篩檢、嚴重感染中斷、免疫接種計畫和避免活性疫苗

## 臨床情境

藥物安全審查
核實適應症、當前評估、劑量和途徑、器官功能、交互作用、緊急毒性線索、授權措施和可測量的後續追蹤。

## 相同主題題目

- [A nurse is reviewing the morning lab results for an adult client receiving warfarin for at…](https://mymerci.kr/pages/nclex_q.php?qn_id=360515&lang=zh-tw)
- [A client is admitted to the emergency department after ingesting an unknown amount of acet…](https://mymerci.kr/pages/nclex_q.php?qn_id=362720&lang=zh-tw)
- [A client with chronic heart failure is prescribed metoprolol 25 mg orally twice daily. Bef…](https://mymerci.kr/pages/nclex_q.php?qn_id=362756&lang=zh-tw)
- [A 28-year-old client with type 1 diabetes receives regular insulin 6 units and NPH insulin…](https://mymerci.kr/pages/nclex_q.php?qn_id=362792&lang=zh-tw)
- [A client receives IV vancomycin 1 g every 12 hours for MRSA bacteremia. Before the next do…](https://mymerci.kr/pages/nclex_q.php?qn_id=362833&lang=zh-tw)
- [A client with bipolar disorder has been taking lithium carbonate 600 mg orally three times…](https://mymerci.kr/pages/nclex_q.php?qn_id=362894&lang=zh-tw)
- [An 80-year-old male with heart failure is prescribed digoxin 0.125 mg daily. During mornin…](https://mymerci.kr/pages/nclex_q.php?qn_id=372686&lang=zh-tw)
- [A 38-year-old female with rheumatoid arthritis is being discharged with a new prescription…](https://mymerci.kr/pages/nclex_q.php?qn_id=372687&lang=zh-tw)

## 以其他語言閱讀

- [en](https://mymerci.kr/pages/nclex_q.php?qn_id=522934&lang=en)
- [ko](https://mymerci.kr/pages/nclex_q.php?qn_id=522934&lang=ko)
- [ja](https://mymerci.kr/pages/nclex_q.php?qn_id=522934&lang=ja)
- [zh-TW](https://mymerci.kr/pages/nclex_q.php?qn_id=522934&lang=zh-tw)
- [vi](https://mymerci.kr/pages/nclex_q.php?qn_id=522934&lang=vi)

---

More free questions: [NCLEX-RN 題庫](https://mymerci.kr/pages/nclex_bank.php?lang=zh-tw)

_僅供學習參考。實際臨床請遵循最新指引與所屬機構規範。_

